iDtheinvestordatabase
Home / Directory / PHX Manco
Likely active: new fund Apr 2023 Verified 5 Nov 2026

PHX Manco

Tempe, AZ venture firm investing in B2B software startups, leading seed and Series A priced rounds and also investing as an LP in software growth funds.

Type
VC firm
Location
Tempe, Arizona, United States
Stages
Pre-seed, Seed, Series A
Backs
B2B software, Medtech and digital health, Consumer apps, Fintech
Sectors
AI, Fintech, Edtech, Healthtech and life sciences, SaaS and software, B2B
Fund size / AUM
$31M gross private fund assets (Form ADV; private funds: 1, of which venture capital: 1)
Portfolio mix
B2B software 33%; Medtech and digital health 19%; Consumer apps 19%; Fintech 15%; Tech-enabled services 7%; Hardware 4%; Marketplaces 4% (n=27)

Contacts on file

For PHX Manco, the paid file holds: 7 named decision-makers with roles; check size; how to pitch (the route the firm publishes); LinkedIn page.

Get US Complete, $197 Free sample

One-time payment. No subscription. No account.

Notable investments

AudiencePlusBasataBearingBetter AgencyBotco.ai

Sources

Last checked 5 Nov 2026. Is something wrong? Tell us.

Appears in 72 lists

Venture capital firms in Arizona (20)Series A edtech investors in the US (21)Pre-seed edtech investors in the US (35)Seed edtech investors in the US (55)Series A edtech investors (58)Pre-seed edtech investors (64)Series A medtech investors in the US (76)Series A B2B investors in the US (79)Series A consumer investors in the US (80)Edtech venture capital firms in the US (83)Pre-seed B2B investors in the US (86)Pre-seed medtech investors in the US (95)Pre-seed consumer investors in the US (104)Seed edtech investors (110)Series A medtech investors (125)Pre-seed medtech investors (129)Series A fintech investors in the US (145)Edtech investors (153)Series A consumer investors (154)Pre-seed B2B investors (155)Series A B2B investors (157)Pre-seed consumer investors (162)Series A healthtech investors in the US (164)Seed B2B investors in the US (183)Pre-seed fintech investors in the US (187)Seed medtech investors in the US (205)Seed consumer investors in the US (216)Pre-seed healthtech investors in the US (225)Series A SaaS investors in the US (256)B2B venture capital firms in the US (257)Seed medtech investors (278)Series A AI investors in the US (280)Series A fintech investors (294)Seed B2B investors (302)Pre-seed fintech investors (323)Seed consumer investors (331)Consumer venture capital firms in the US (348)Seed fintech investors in the US (349)Medtech venture capital firms in the US (350)Pre-seed SaaS investors in the US (367)Series A investors in the US (372)Series A healthtech investors (401)Pre-seed AI investors in the US (403)Pre-seed healthtech investors (408)Seed healthtech investors in the US (437)B2B investors (438)Medtech investors (457)Series A SaaS investors (475)Series A AI investors (500)Consumer investors (512)Fintech venture capital firms in the US (525)Pre-seed investors in the US (549)Pre-seed SaaS investors (562)Seed fintech investors (584)Pre-seed AI investors (633)Seed SaaS investors in the US (666)Healthtech venture capital firms in the US (709)Seed AI investors in the US (724)Seed healthtech investors (800)Fintech investors (846)Series A investors (864)Pre-seed investors (988)Seed SaaS investors (1,010)Seed investors in the US (1,043)SaaS venture capital firms in the US (1,049)Seed AI investors (1,082)AI venture capital firms in the US (1,112)Healthtech investors (1,207)SaaS investors (1,529)AI investors (1,576)Seed investors (1,892)Venture capital firms in the US (2,975)